NCT06528197招募中不适用
Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese Medicine and Western Medicine Based on Multi-omics
China-Japan Friendship Hospital1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2024年7月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Number of participants with system involvement
研究概览
简要总结
This study aims to establish a large sample cohort of patients with primary sjogren's syndrome, collect multi-omics information of patients with primary sjogren's syndrome, and construct disease diagnosis model and disease prognosis prediction model.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Meets the 2002 AECG or 2016 ACR/EULAR classification criteria of primary Sjögren's syndrome.
排除标准
- •Comorbid connective tissue disease other than the disease under research.
- •Women who are pregnant or breastfeeding.
- •Combined severe cardiovascular or cerebrovascular disease, hepatic or renal failure, or severe malignant tumors.
- •Other conditions (e.g., cognitive impairment) that the investigators consider ineligible for enrollment.
结局指标
主要结局
Number of participants with system involvement
时间窗: Baseline , 6 months follow-up
System involvement determined from clinical diagnosis
次要结局
- Mortality(Baseline , 6 months follow-up)
- Number of participants with tumor(Baseline , 6 months follow-up)
- Number of participants with connective tissue disease(Baseline , 6 months follow-up)
研究者
Qingwen Tao
Chief physician
China-Japan Friendship Hospital
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome PatientsSjogren's SyndromeNCT04916756Peking Union Medical College Hospital11
尚未招募
不适用
Standardization study of Sjogren's syndrome based on epidemiological investigation and cohort studySjogren's syndromeITMCTR1900002438Chongqing Hospital of Traditional Chinese Medicine
已完成
2 期
Efficacy and Safety of Belimumab in Primary Sjögren's SyndromeSjögren's SyndromeNCT01008982University of Udine15
撤回
1 期
Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's SyndromePrimary Sjögren's SyndromeNCT02495129Novartis Pharmaceuticals
已完成
3 期
Efficacy and Safety of Abatacept in Patients With Primary Sjögren's SyndromeSjögren's SyndromeNCT02067910University Medical Center Groningen80